Nilotinib inhibits the Src-family kinase LCK and T-cell function in vitro

被引：26

作者：

Blake, Stephen J. ^{[1
,2
]}

Lyons, A. Bruce ^{[1
,3
]}

Hughes, Timothy P. ^{[1
,3
]}

机构：

[1] IMVS Adelaide, Hanson Inst Canc Res, Adelaide, SA, Australia

[2] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia

[3] Univ Adelaide, Sch Hlth Sci, Adelaide, SA, Australia

来源：

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2009年 / 13卷 / 03期

关键词：

PROLIFERATION;

D O I：

10.1111/j.1582-4934.2009.00500_1.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页数：5

共 9 条

[1] Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling [J].

Chen, J. ;

Schmitt, A. ;

Chen, B. ;

Rojewski, M. ;

Ruesseler, V. ;

Fei, F. ;

Yu, Y. ;

Yu, X. ;

Ringhoffer, M. ;

von Harsdorf, S. ;

Greiner, J. ;

Goetzz, M. ;

Guillaume, P. ;

Doehner, H. ;

Bunjes, D. ;

Schmitt, M. .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5B) :2107-2118

[2] Defective T cell development and function in the absence of Abelson kinases [J].

Gu, Jing Jin ;

Zhang, Nu ;

He, You-Wen ;

Koleske, Anthony J. ;

Pendergast, Ann Marie .

JOURNAL OF IMMUNOLOGY, 2007, 179 (11) :7334-7343

[3] The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse [J].

Huang, Yanping ;

Comiskey, Erin O. ;

Dupree, Renell S. ;

Li, Shuixing ;

Koleske, Anthony J. ;

Burkhardt, Janis K. .

BLOOD, 2008, 112 (01) :111-119

[4] DETERMINATION OF LYMPHOCYTE DIVISION BY FLOW-CYTOMETRY [J].

LYONS, AB ;

PARISH, CR .

JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 171 (01) :131-137

[5]

MANLEY PW, 2007, AM ASS CANC RES, P3249

[6] PROFOUND BLOCK IN THYMOCYTE DEVELOPMENT IN MICE LACKING P56(LCK) [J].

MOLINA, TJ ;

KISHIHARA, K ;

SIDEROVSKI, DP ;

VANEWIJK, W ;

NARENDRAN, A ;

TIMMS, E ;

WAKEHAM, A ;

PAIGE, CJ ;

HARTMANN, KU ;

VEILLETTE, A ;

DAVIDSON, D ;

MAK, TW .

NATURE, 1992, 357 (6374) :161-164

[7] In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants [J].

O'Hare, T ;

Walters, DK ;

Stoffregen, EP ;

Jia, TP ;

Manley, PW ;

Mestan, J ;

Cowan-Jacob, SW ;

Lee, FY ;

Heinrich, MC ;

Deininger, MWN ;

Druker, BJ .

CANCER RESEARCH, 2005, 65 (11) :4500-4505

[8] Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner [J].

Seggewiss, R ;

Loré, K ;

Greiner, E ;

Magnusson, MK ;

Price, DA ;

Douek, DC ;

Dunbar, CE ;

Wiestner, A .

BLOOD, 2005, 105 (06) :2473-2479

[9] Requirement for Abl kinases in T cell receptor signaling [J].

Zipfel, PA ;

Zhang, WG ;

Quiroz, M ;

Pendergast, AM .

CURRENT BIOLOGY, 2004, 14 (14) :1222-1231

← 1 →